Aquatic Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-14,348
| Closed | -$3.87M | – | 1221 |
|
|
2025
Q1 | $3.87M | Sell |
14,348
-26,204
| -65% | -$7.08M | 0.1% | 265 |
|
|
2024
Q4 | $9.54M | Buy |
40,552
+20,143
| +99% | +$4.74M | 0.26% | 100 |
|
|
2024
Q3 | $5.61M | Buy |
20,409
+17,209
| +538% | +$4.73M | 0.15% | 171 |
|
|
2024
Q2 | $778K | Sell |
3,200
-18,600
| -85% | -$4.52M | 0.03% | 450 |
|
|
2024
Q1 | $3.26M | Buy |
21,800
+900
| +4% | +$135K | 0.11% | 186 |
|
|
2023
Q4 | $4M | Buy |
20,900
+3,000
| +17% | +$574K | 0.1% | 204 |
|
|
2023
Q3 | $3.17M | Buy |
+17,900
| New | +$3.17M | 0.13% | 171 |
|
|
2023
Q2 | – | Sell |
-21,300
| Closed | -$4.27M | – | 1297 |
|
|
2023
Q1 | $4.27M | Buy |
+21,300
| New | +$4.27M | 0.26% | 105 |
|
|
2022
Q2 | – | Sell |
-200
| Closed | -$33K | – | 1167 |
|
|
2022
Q1 | $33K | Buy |
+200
| New | +$33K | 0.05% | 373 |
|